QDEL

21.28

+0.9%↑

NERV

4.1

-4.65%↓

LSTA.US

1.99

-1.49%↓

QDEL

21.28

+0.9%↑

NERV

4.1

-4.65%↓

LSTA.US

1.99

-1.49%↓

QDEL

21.28

+0.9%↑

NERV

4.1

-4.65%↓

LSTA.US

1.99

-1.49%↓

QDEL

21.28

+0.9%↑

NERV

4.1

-4.65%↓

LSTA.US

1.99

-1.49%↓

QDEL

21.28

+0.9%↑

NERV

4.1

-4.65%↓

LSTA.US

1.99

-1.49%↓

Home・Akciju saraksts・Pharming Group NV

P
Pharming Group NV

Atvērts

1.39 1.46

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

1.357

Max

1.407

Galvenie mērījumi
By Trading Economics
Ienākumi	2.9M 7.5M
Pārdošana	4.1M 97M
EPS	0.009
Peļņas marža	7.758
Darbinieki	404

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	-43M 954M
Iepriekšējā atvēršanas cena	-0.07
Iepriekšējā slēgšanas cena	1.39

Pharming Group NV Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 18. nov. 19:25 UTC

Iegādes, apvienošanās, pārņemšana

Canada Says Anglo American's Pledges to Secure Teck Resources Deal Not Enough -- 2nd Update

2025. g. 18. nov. 18:09 UTC

Iegādes, apvienošanās, pārņemšana

Canada Says Anglo American's Pledges to Secure Teck Resources Deal Not Enough -- Update

2025. g. 18. nov. 17:39 UTC

Iegādes, apvienošanās, pārņemšana

Canada Says Anglo American's Pledges to Secure Teck Resources Deal Not Enough

2025. g. 18. nov. 16:25 UTC

Galvenie tirgus virzītāji

Diginex Rises on Deal With Digital Asset Platform Evident

2025. g. 18. nov. 23:56 UTC

Tirgus saruna

Gold Edges Higher on Likely Technical Recovery -- Market Talk

2025. g. 18. nov. 23:39 UTC

Tirgus saruna

Nikkei May Rise on Bargain-Hunting Interest -- Market Talk

2025. g. 18. nov. 22:59 UTC

Tirgus saruna

FireFly Metals Can Build Bigger Operation at Green Bay -- Market Talk

2025. g. 18. nov. 22:08 UTC

Tirgus saruna

Sandfire's Kalkaroo Project Push Adds to Copper M&A Surge -- Market Talk

2025. g. 18. nov. 22:03 UTC

Iegādes, apvienošanās, pārņemšana

Meta Defeats FTC's Antitrust Case Alleging Social-Media Monopoly -- 3rd Update

2025. g. 18. nov. 22:03 UTC

Peļņas

These Stocks Moved the Most Today: Nvidia, Microsoft, Home Depot, Cloudflare, Energizer, Honeywell, Medtronic, Klarna, and More -- Barrons.com

2025. g. 18. nov. 21:50 UTC

Tirgus saruna

Financial Services Roundup: Market Talk

2025. g. 18. nov. 21:50 UTC

Tirgus saruna

Auto & Transport Roundup: Market Talk

2025. g. 18. nov. 21:15 UTC

Tirgus saruna

Private High-Grade Credit Market Is Changing, BlackRock Says -- Market Talk

2025. g. 18. nov. 20:46 UTC

Tirgus saruna

U.S. Natural Gas Futures Edge Up on Weather Outlook -- Market Talk

2025. g. 18. nov. 20:13 UTC

Tirgus saruna

Distillate Supply Concerns Pull Crude Futures Higher -- Market Talk

2025. g. 18. nov. 19:48 UTC

Tirgus saruna

Gold and Silver Turn Lower on Fed Outlook -- Market Talk

2025. g. 18. nov. 19:19 UTC

Iegādes, apvienošanās, pārņemšana

Anheuser-Busch InBev Nears $700 Million Deal for Party Punch Maker BeatBox -- WSJ

2025. g. 18. nov. 19:19 UTC

Iegādes, apvienošanās, pārņemšana

Anheuser-Busch InBev in Talks to Buy Party Punch Maker BeatBox, Sources Say -- WSJ

2025. g. 18. nov. 19:19 UTC

Iegādes, apvienošanās, pārņemšana

AB InBev-BeatBox Deal Could Come Together Soon, Sources Say -- WSJ

2025. g. 18. nov. 19:19 UTC

Iegādes, apvienošanās, pārņemšana

AB InBev Deal Would Value BeatBox At Around $700M, Sources Say -- WSJ

2025. g. 18. nov. 18:29 UTC

Peļņas

These Stocks Are Moving the Most Today: Nvidia, Microsoft, Home Depot, Cloudflare, Energizer, Honeywell, Medtronic, Klarna, and More -- Barrons.com

2025. g. 18. nov. 18:18 UTC

Tirgus saruna

Ethanol Demand Expected to Boost Corn Futures -- Market Talk

2025. g. 18. nov. 17:20 UTC

Tirgus saruna

Auto & Transport Roundup: Market Talk

2025. g. 18. nov. 17:20 UTC

Tirgus saruna

Health Care Roundup: Market Talk

2025. g. 18. nov. 17:19 UTC

Tirgus saruna

Peļņas

Good Weather Was Bad News for Home Depot's 3Q -- Market Talk

2025. g. 18. nov. 17:06 UTC

Peļņas

Medtronic Stock Rises After Earnings. What Caught Investors' Attention. -- Barrons.com

2025. g. 18. nov. 16:06 UTC

Iegādes, apvienošanās, pārņemšana

Intuit Stock Gains on OpenAI Deal. ChatGPT Is Coming to TurboTax. -- Barrons.com

2025. g. 18. nov. 15:59 UTC

Peļņas

Home Depot Cuts Outlook as Home Improvement Slowdown Continues -- Update

2025. g. 18. nov. 15:35 UTC

Iegādes, apvienošanās, pārņemšana

Eni: Acquisition Adds to Plenitude's Installed-Capacity Targets, Bolsters France Presence

2025. g. 18. nov. 15:35 UTC

Iegādes, apvienošanās, pārņemšana

Eni: Portfolio Comprises Capacity of Around 760MW in Operation

Salīdzinājums

Cenas izmaiņa

Pharming Group NV Prognoze

Vērtējuma vienprātība

By TipRanks

0 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 0 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Pharming Group NV — pēdējo 3 mēnešu laikā.

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par Pharming Group NV

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K" inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.